Copyright
©The Author(s) 2004.
World J Gastroenterol. Nov 1, 2004; 10(21): 3099-3102
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3099
Published online Nov 1, 2004. doi: 10.3748/wjg.v10.i21.3099
Table 1 Baseline patient characteristics
| OTCG | TG | CG | P < | |
| M:F ratio | 27:14 | 17:13 | 18:12 | NS |
| Age (yr) | 55.3 ± 1.8 | 54.6 ± 2.1 | 57.2 ± 2.0 | NS |
| AST (U/L) | 67.1 ± 6.6 | 61.9 ± 7.2 | 79.4 ± 8.4 | NS |
| ALT (U/L) | 92.5 ± 10.8 | 79.8 ± 8.7 | 91.8 ± 9.1 | NS |
| γ GT (U/L) | 56.5 ± 7.2 | 52.1 ± 7.3 | 65.2 ± 9.4 | NS |
| Albumin (g/dL) | 4.2 ± 0.07 | 4.2 ± 0.07 | 4.1 ± 0.06 | NS |
| α 1feto (ng/mL) | 6.8 ± 1.25 | 8.4 ± 2.36 | 6.3 ± 1.0 | NS |
| HCV1b | 63% | 67% | 65% | NS |
| AgNOR-PI (%) | 20.1 ± 2.35 | 19.6 ± 2.84 | 18.2 ± 2.6 | NS |
- Citation: Francesco A, Esterita A, Giovanni N, Davide T, Silvia G, Anna M, Francesca L, Marco M, Mariarosa T, Antonio C, Constance M, Davide F, Enrico R, Massimo D, Giuseppe M. Interferon plus ribavirin and interferon alone in preventing hepatocellular carcinoma: A prospective study on patients with HCV related cirrhosis. World J Gastroenterol 2004; 10(21): 3099-3102
- URL: https://www.wjgnet.com/1007-9327/full/v10/i21/3099.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i21.3099